Clinical and serological characteristics of the 67 patients with idiopathic inflammatory myopathies (IIM) included in the longitudinal analyses defined by anti-FHL1 autoantibody status. The gene discussed is FHL1; the disease is acquired idiopathic inflammatory myopathy.